MindMed Appoints Schond L. Greenway As CFO

Mind Medicine Inc. MNMD, MMED, a clinical stage bio-pharmaceutical company developing novel products to treat brain health disorders, appointed Schond L. Greenway as CFO. Greenway comes to MindMed with over 20 years of experience in investment banking, finance and corporate advisory, and investment analysis in the life sciences sector.

“We are very excited to add Schond to our management team. Schond brings extensive expertise in US biotech capital markets, which was a key attribute we sought in identifying a CFO,” stated Robert Barrow, CEO and director of MindMed. “Schond is joining MindMed at an exciting point in our growth, with numerous near-term milestones ahead across our pipeline. I look forward to working closely with him to advance our mission of becoming a global leader in the development of innovative therapies for brain health disorders.”

Greenway joins MindMed after serving as CFO of Avalo Therapeutics AVTX, a precision medicine clinical stage bio-pharmaceutical company. He previously served as VP of investor relations at Mesoblast MEOBF, an allogeneic cellular medicines company. He served in a similar role at Halozyme Therapeutics, Inc. HALO and in various roles at investment banking firms Morgan Stanley MS and Barclays Capital, predominantly focused on healthcare and technology.

Photo: Courtesy of Cytonn Photography on Unsplash

Related News

MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance

MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year

Can LSD Treat Anxiety? MindMed's New Topline Data Show Promise, Here's The Research

 

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisNewsPenny StocksPsychedelicsSmall CapMarketsBarclays CapitalRobert BarrowSchond L. Greenway
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...